Tag: Prescription Drugs

Asian, Black, Hispanic, and low-income patients less likely to receive treatment with a glucagon-like peptide-1 receptor agonist for T2DM

Biden also announced that his administration is doubling its order of new Pfizer antiviral pill

Greatest decline in incident stimulant and anxiolytic/sedative-hypnotic medications was in quarter 2 of 2020

Machine learning integrating clinical and genomic data can predict methotrexate treatment response in early rheumatoid arthritis

Rate of serious adverse events similar for participants receiving dolutegravir, standard care as first-, second-line treatment for HIV-1 infection

No measurable difference in patient-rated quality of life seen for dopamine agonists versus dopamine reuptake inhibitors as adjuvant therapy

In phase 2 trial, spesolimab cleared more lesions than placebo, but it was associated with infections, systemic drug reactions

Three-day course of treatment results in reduced risk for hospitalization or death compared with placebo

Further study needed to determine whether bamlanivimab could benefit patients who are negative for endogenous neutralizing antibodies

Drug unaffordability is an issue regardless of insurance status and across private, public payers